The Scientist

» pharmaceuticals and disease/medicine

Most Recent

image: Week in Review: February 22–26

Week in Review: February 22–26

By | February 26, 2016

Questions about how E. coli evolves; spermatids in a dish; fighting bacteria with virus-like molecule; what drives metastasis; antibodies fight Ebola in monkeys

0 Comments

image: Detecting Lyme Early

Detecting Lyme Early

By | February 12, 2016

Two new methods could help researchers to diagnose Lyme disease earlier than with existing tests.

0 Comments

image: Neanderthals’ Genetic Legacy

Neanderthals’ Genetic Legacy

By | February 11, 2016

Ancient DNA in the genomes of modern humans influences a range of physiological traits.

6 Comments

image: Aging Shrinks Chromosomes

Aging Shrinks Chromosomes

By | February 5, 2016

A study on human cells reveals how cellular aging affects the 3-D architecture of chromosomes.

0 Comments

image: Abbott Acquires Diagnostics Firm

Abbott Acquires Diagnostics Firm

By | February 2, 2016

In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.

0 Comments

image: Contributors

Contributors

By | February 1, 2016

Meet some of the people featured in the February 2016 issue of The Scientist.

0 Comments

image: Marriages of Opportunity

Marriages of Opportunity

By | February 1, 2016

New ideas for antibody-drug conjugate design

0 Comments

image: The Mycobiome

The Mycobiome

By | February 1, 2016

The largely overlooked resident fungal community plays a critical role in human health and disease.

10 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham